As PayPal prepares to report its fourth-quarter results, investors are watching closely for signs of resilience in its core business and updates on its strategic turnaround efforts. The report could set the tone for the broader fintech sector.
BellRing Brands prepares to release its fourth-quarter financial results, with analysts forecasting a revenue dip. The report comes as investors gauge the resilience of the shelf-stable nutrition segment.
Archer-Daniels-Midland (ADM) is set to report Q4 earnings Tuesday morning. Analysts project a slight revenue dip, but investor sentiment remains cautiously optimistic as the agribusiness leader navigates a volatile global market.
As Pfizer prepares to report its fourth-quarter results, investors are weighing the company's strategic pivot beyond its COVID-19 portfolio against a backdrop of expected revenue declines. The report may set the tone for the broader pharmaceutical sector.
As Transcat prepares to release its quarterly results, investors are weighing its strong revenue growth trajectory against a history of earnings volatility. The industrial distributor's performance will be a key test amid mixed signals from the sector.
As Ingredion prepares to release its fourth-quarter results, investors are weighing whether the company can stabilize after a disappointing prior quarter. The broader staples sector's recent strength offers a cautiously optimistic backdrop.
A Minnesota judge orders the release of Liam Conejo Ramos and his father from a Texas ICE facility, citing 'traumatizing children' in pursuit of deportation quotas. The case sparked national outrage over the treatment of asylum-seeking families.
Health and Human Services Secretary Robert F. Kennedy Jr. has publicly addressed the deep divisions within America's most storied political family, following the death of his cousin Tatiana Schlossberg and amidst ongoing policy controversies that have placed him at odds with his relatives.
President Donald Trump has declared the 'Trump Kennedy Center' will shut its doors this July for an extensive two-year renovation, a move following artist boycotts and declining attendance since his controversial takeover and renaming of the iconic institution.
A fatal bus crash in southern Turkey's Antalya province has claimed nine lives and injured 26 others, with authorities citing wet roads, fog, and suspected speeding as contributing factors in the Sunday morning tragedy.
Driven by robust subscriber growth, a surge in free cash flow, and a new $10 billion buyback plan, AT&T's stock rallied over 10% this week, signaling renewed investor confidence in the telecom giant's convergence strategy.
As artificial intelligence drives an unprecedented surge in electricity demand, one utility company—Constellation Energy—is uniquely positioned with its vast nuclear fleet to meet the need, turning an industry-wide bottleneck into a significant growth opportunity.
Panera Bread is closing its Franklin, Mass., bakery facility next month, resulting in 92 layoffs, as the chain transitions from fresh dough to a centralized parbaking system for its breads and pastries.
The Northern Ireland Executive has suspended a planned revaluation of hotel business rates, averting significant tax increases for accommodation providers slated for 2026 and providing temporary stability for the region's tourism industry.
Shares of materials and labeling giant Avery Dennison (NYSE: AVY) have shown resilience amid broader market swings, reigniting debate over its intrinsic value. With a significant gap between its current price and analyst targets, investors are weighing its growth in digital identification technologies against persistent sector headwinds.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
Vital Farms (VITL) is drawing renewed investor attention following a series of earnings estimate upgrades and consistent beats. Despite a recent pullback, analysts see significant upside, citing strong brand positioning and operational scale. However, underlying challenges in retail volumes and cash flow present a more complex picture for the pasture-raised egg producer.
Exelixis has filed its next-generation therapy zanzalintinib with U.S. regulators for metastatic colorectal cancer, marking a significant step in its clinical development and potentially enhancing its competitive position in the targeted oncology space.
A new poll indicates Prime Minister Sanae Takaichi's ruling coalition is on track for a decisive win in next week's lower house election, potentially strengthening her mandate for expansive fiscal policies.
The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.
